LIFELINK FOUNDATION INC

Lifelink transplantation immunology laboratory: lifelink transplantation immunology laboratory brings the legacy established by organ donors and their families to life by serving as the matchmaker between organ donors and potential transplant recipients. We continue to honor donors by ensuring the longevity of renewed life with diligent post-transplant monitoring and innovative research to improve patient care. (continued on schedule o)during the 2024 fiscal year, the lifelink transplantation immunology laboratory facilitated 1,089 lifesaving transplants for six transplant centers served. They also evaluated 641 living donors and 961 deceased donors and conducted over 43,000 transplant related tests. In addition, the lifelink transplantation immunology laboratory implemented hla typing by next-generation sequencing (ngs) to better assess the compatibility of a donor and a potential recipient.

Research and development: the primary goal of lifelink is to recover lifesaving organs and tissues for transplantation. However, there are instances when those organs and/or tissues are unable to be transplanted, in which case they can still be directed to help others in need through research initiatives. Research and development aids lifelink efforts to maximize all gifts of donation with a shared goal to benefit donation and transplantation outcomes through scientific endeavors.

Public education: public and professional education in georgia, florida, and puerto rico: the public affairs and multicultural donation education program teams work to provide donation education and increase donor registration across various audiences including driver license issuing offices, hospitals, youth, faith, and minority communities. Lifelink utilizes volunteers throughout our service areas to share donation and transplant stories while encouraging individuals to make a lifesaving decision by registering to be an organ and tissue donor. Through this outreach and education, more than 1,555,520 individuals in florida, georgia, and puerto rico registered as organ and tissue donors during the 2024 fiscal year.